id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0421-0006,FDA,FDA-2008-P-0421,FDA/CDER to Buchanan Ingersoll & Rooney PC  - Peititon Denial,Other,PDN-Petition Denial,2010-12-17T05:00:00Z,2010,12,2010-12-17T05:00:00Z,,2013-07-27T23:39:59Z,,0,0,0900006480bb95a1
FDA-2008-P-0421-0005,FDA,FDA-2008-P-0421,"Aton Pharma, Inc., (Buchanan Ingersoll & Rooney PC) - Petition for Stay",Other,PSA-Petition for Stay,2010-04-26T04:00:00Z,2010,4,2010-04-26T04:00:00Z,,2013-07-27T23:16:12Z,,0,0,0900006480adb193
FDA-2008-P-0421-0004,FDA,FDA-2008-P-0421,"FDA/CDER Response to Lachman Consultant Services, Inc. - Petition Approval",Other,PAV-Petition Approval,2010-03-29T04:00:00Z,2010,3,2010-03-29T04:00:00Z,,2013-08-11T04:38:43Z,,0,0,0900006480ac4ab3